Enhancement to the Benefit Funds’ Medical Oncology Review Program
Beginning on January 1, 2023, the 1199SEIU Benefit Funds’ Medical Oncology Review Program will accept prior authorization requests for standard of care medical oncology drugs administered during pediatric and adult medical oncology clinical trials through eviCore Healthcare. To submit your requests, visit www.eviCore.com or call (888) 910-1199.
The Benefit Funds have partnered with eviCore healthcare (formerly CareCore National) to pre-authorize and review claims for high-tech radiology and nuclear cardiology scans, radiation therapy, medical oncology treatments and certain outpatient molecular and genomic laboratory services. This partnership will allow providers to access eviCore’s experts, as well as their nationally recognized evidence-based guidelines and criteria, to help ensure that 1199SEIU patients receive clinically appropriate care in a timely manner.
Each program has its own page, which includes specific requirements and key information. As our programs are subject to updates, we encourage you to view the program pages on a regular basis to ensure you have the most up-to-date information.
In addition to prior authorization, eviCore will review claims for coding accuracy and medical necessity. We urge you to update your claims submission system and coding practices accordingly to avoid payment delays or unnecessary denials.
Further Detail on Each Program
Save Time and Receive Immediate Response! Submit your eviCore Prior Approval Requests Electronically
eviCore offers an immediate response and an email notification through its online portal to authorization requests that meet the 1199SEIU Benefit Funds’ criteria.